北美生物加工市场预测至 2031 年 - 区域分析 - 按产品（仪器和消耗品及配件）、运营规模（商业运营和临床运营）、工艺（下游生物工艺和上游生物工艺）、应用（单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等）和最终用户（生物制药公司、合同制造组织等）
慢性病患病率不断上升推动北美生物加工市场发展
老年人久坐不动的生活方式加剧了肥胖和糖尿病等生活方式疾病的患病率。遗传基因也会导致这些疾病以及其他健康问题，如心血管疾病 (CVD)、阿尔茨海默病和抑郁症。根据美国国家老龄委员会的数据，80% 的成年人（65 岁及以上）报告称其一生中至少患有一种慢性病。根据美国疾病控制和预防中心 (CDC) 的数据，2020 年，美国大约有 60% 的人患有至少一种严重疾病，40% 的人患有两种或两种以上的慢性病。据世界卫生组织称，2020 年，60 岁以上的成年人口多于 5 岁以下的儿童。2015 年至 2050 年间，全球 60 岁以上人口的比例将从 12% 增加近一倍至 22%。已知痴呆、骨关节炎、癌症、中风和心血管疾病等许多慢性疾病都与衰老有关。由于忙碌的生活方式引起的心绞痛、动脉粥样硬化和急性心肌梗死等心血管疾病是全球死亡的主要原因。根据世界心脏基金会的数据，过去 30 年间（1990-2020 年），因心血管疾病导致的死亡率飙升了 60%。 2021 年，心血管疾病导致的死亡人数达 2050 万。糖尿病是一种危及生命的慢性疾病，目前尚无治愈方法。所有类型的糖尿病都会导致身体不同部位出现各种并发症，从而增加总体死亡风险。根据国际糖尿病联合会的数据，北美糖尿病病例数预计将从 2017 年的 4600 万增加到 2045 年的 6200 万。此外，2017 年有 4.25 亿人患有糖尿病，预计到 2045 年全球糖尿病患者人数将达到 6.29 亿，增幅约为 35%。根据 2020 年发布的全球癌症观察站 (GLOBOCAN) 估计，全球报告了 1930 万例癌症病例。美国、中国和印度的病例数显著增加。同样，根据世界卫生组织 2022 年 2 月发布的数据，全球约有 1000 万人死于癌症。癌症发病率的上升表明需要创新的癌症治疗方法。单克隆抗体代表了一类有前途的靶向抗癌剂，可增强免疫系统抑制癌细胞活动和消除癌细胞的自然能力。抗体-药物偶联物 (ADC) 在癌症治疗中也显示出有希望的结果。专家、患者、初级保健临床医生和其他医疗保健专业人员认识到生物仿制药的高效性和安全性，这推动了其需求。生物仿制药已被证明可以改善数百万患者的生活质量。它们是治疗许多疾病的有效且具有成本效益的选择，包括慢性皮肤病（如牛皮癣和特应性皮炎）、肠道疾病（如克罗恩病、肠易激综合征和结肠炎）、糖尿病、自身免疫性疾病、癌症、肾脏疾病和关节炎。生物仿制药开发商正在采用先进的生物加工技术来降低制造成本，这是决定最终消费者价格的重要因素。几乎所有的生物仿制药开发商都在使用现代的、尖端的生物加工技术。因此，随着慢性病的日益流行，对治疗危及生命的疾病的生物仿制药的需求正在激增，从而推动了对生物加工的需求。
北美生物加工市场概览
遗传和细胞疾病的发病率不断上升，导致对细胞疗法的需求不断增加。美国制药研究和制造商协会 (PhRMA) 关于细胞和基因治疗管道的报告（2020 年发布）显示，美国有 400 种细胞和基因疗法正在开发中，用于治疗从癌症到遗传疾病再到神经系统疾病的各种疾病和病症。2023 年 4 月，Cytiva 推出了 X-platform 生物反应器，以使用一次性产品简化上游生物加工操作。最初，这些生物反应器的尺寸为 50 L 和 200 L。X-Platform 生物反应器现在配备了 Figurate 自动化解决方案软件，可以通过人体工程学改进、生产能力和简化供应链运营来提高流程效率。
生物制药行业的增长主要归功于技术进步、灵活性提高和运营成本降低，这也使美国的生物加工市场受益。根据国际贸易管理局 (ITA) 的数据，美国是最大的生物制药市场，也是全球研发领域的领先者。根据 PhRMA 的数据，美国公司占全球生物制药研发工作的近 50%，并且他们成功开发了许多拥有知识产权的新型药物。因此，美国生物制药和生物技术公司为改善临床试验结果和确保患者安全而增加的研发投资，以及美国政府不断增加的投资对精准医疗的日益关注，都促进了美国生物加工市场的增长。
北美生物加工市场收入和预测到 2031 年（百万美元）
北美生物加工市场细分
北美生物加工市场分为产品、运营规模、流程、应用、最终用户和国家。
根据产品，北美生物加工市场分为仪器和消耗品及配件。仪器部门在 2023 年占据了更大的市场份额。此外，仪器部门细分为过滤设备、生物反应器、色谱系统、离心机、干燥设备等。此外，生物反应器子部分分为中试规模、全规模和实验室规模。此外，色谱系统子部分细分为液相色谱、气相色谱等。此外，消耗品和配件部分细分为试剂、细胞培养基、色谱树脂等。
就运营规模而言，北美生物加工市场分为商业运营和临床运营。商业运营部门在 2023 年占据了更大的市场份额。
按工艺，北美生物加工市场分为下游生物工艺和上游生物工艺。下游生物工艺部门在 2023 年占据了更大的市场份额。
根据应用，北美生物加工市场分为单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等。单克隆抗体部门在 2023 年占据了最大的市场份额。
就最终用户而言，北美生物加工市场分为生物制药公司、合同制造组织等。 2023 年，生物制药公司占据了最大的市场份额。
按国家/地区划分，北美生物加工市场分为美国、加拿大和墨西哥。2023 年，美国占据了北美生物加工市场份额的主导地位。
Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC 是北美生物加工市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. North America Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - North America Analysis
6.1 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. North America Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. North America Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. North America Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. North America Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. North America Bioprocessing Market - Country Analysis
12.1 North America: Bioprocessing Market Overview
12.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
12.1.1.1 United States: Bioprocessing Market- Revenue and Forecast to 2031 (US$ Million)
12.1.1.2 Overview
12.1.1.3 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 United States: Bioprocessing Market Breakdown, by Product
12.1.1.3.1.1 United States: Bioprocessing Market Breakdown, by Instruments
12.1.1.3.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.3.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.3.1.2 United States: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.3.2 United States: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.3.3 United States: Bioprocessing Market Breakdown, by Process
12.1.1.3.4 United States: Bioprocessing Market Breakdown, by Application
12.1.1.3.5 United States: Bioprocessing Market Breakdown, by End User
12.1.1.4 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Overview
12.1.1.5 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Canada: Bioprocessing Market Breakdown, by Product
12.1.1.5.1.1 Canada: Bioprocessing Market Breakdown, by Instruments
12.1.1.5.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.5.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.5.1.2 Canada: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.5.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.5.3 Canada: Bioprocessing Market Breakdown, by Process
12.1.1.5.4 Canada: Bioprocessing Market Breakdown, by Application
12.1.1.5.5 Canada: Bioprocessing Market Breakdown, by End User
12.1.1.6 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Overview
12.1.1.7 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Mexico: Bioprocessing Market Breakdown, by Product
12.1.1.7.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments
12.1.1.7.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.7.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.7.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.7.2 Mexico: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.7.3 Mexico: Bioprocessing Market Breakdown, by Process
12.1.1.7.4 Mexico: Bioprocessing Market Breakdown, by Application
12.1.1.7.5 Mexico: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. North America Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 35. Recent Organic Growth Strategies in the Bioprocessing Market
Table 36. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. North America Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. North America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.